An overnight insulin infusion algorithm provides morning normoglycemia and can be used to predict insulin requirements in noninsulin-dependent diabetes mellitus.

Initial insulin requirements in noninsulin-dependent diabetes mellitus (NIDDM) are difficult to estimate because of individual variability in insulin sensitivity and secretion. We evaluated a simple, nurse-managed algorithm for overnight delivery of insulin, for its ability to provide morning near-normoglycemia and as a means to predict initial insulin requirements in NIDDM. Twenty-seven patients with poorly controlled NIDDM were studied on 30 occasions. A 12-h iv insulin infusion was begun at 2000 h, and bedside blood glucose concentrations were measured at hourly intervals. The rate of insulin infusion was adjusted according to blood glucose levels. We estimated the preprandial insulin dose requirement for the following day in 16 patients based on overnight insulin requirements to maintain normoglycemia. Preprandial insulin doses were adjusted for prevailing blood glucose concentrations. At 2000 h, the mean (+/-SEM) blood glucose concentration was 265.7 +/- 10.8; at 0300 h, it was 122.8 +/- 3.4; and at 0700 h, it was 123.8 +/- 5.1 mg/dL. On the next day, mean blood glucose levels (before and 2 h after a meal) were: breakfast, 102.5 +/- 5.9 and 177.3 +/- 19.2; lunch, 138.9 +/- 15.5 and 136.3 +/- 11.4; dinner, 105.7 +/- 7.2 and 178.1 +/- 15.7 mg/dL. There was no significant difference between mean calculated and administered total insulin dosage the next day (84.2 +/- 7.0 vs. 78.2 +/- 8.2 U). Thus, a weight-based algorithm for iv insulin infusion induced near-normoglycemia in NIDDM and successfully predicted the insulin dose requirement. We conclude that initiating insulin therapy in NIDDM patients can be achieved rapidly and efficiently based on a nurse-managed overnight insulin infusion.

[1]  J. Olefsky,et al.  Mechanisms of insulin resistance in obesity and noninsulin-dependent (type II) diabetes. , 1981, The American journal of medicine.

[2]  J. Leahy,et al.  β-Cell Dysfunction Induced by Chronic Hyperglycemia: Current Ideas on Mechanism of Impaired Glucose-Induced Insulin Secretion , 1992, Diabetes Care.

[3]  W. Clarke,et al.  Overnight Basal Insulin Requirements in Fasting Insulin-dependent Diabetics , 1980, Diabetes.

[4]  H. Shamoon,et al.  The Pharmacological Treatment of Hyperglycemia in NIDDM , 1996, Diabetes Care.

[5]  A. Schiffrin,et al.  Combined Continuous Subcutaneous Insulin Infusion and Multiple Subcutaneous Injections in Type I Diabetic Patients , 1981, Diabetes Care.

[6]  M. Buysschaert,et al.  Use of an artificial pancreas as a tool to determine subcutaneous insulin doses in juvenile diabetes , 1979, Diabetes Care.

[7]  E. Ipp,et al.  Accuracy of Plasma Glucose Measurements in the Hypoglycemic Range , 1994, Diabetes Care.

[8]  D. Singer,et al.  The clinical information value of the glycosylated hemoglobin assay. , 1984, The New England journal of medicine.

[9]  J. Gerich,et al.  A simple insulin infusion algorithm for establishing and maintaining overnight near-normoglycemia in type I and type II diabetes. , 1992, The Journal of clinical endocrinology and metabolism.

[10]  N. White,et al.  Practical closed-loop insulin delivery. A system for the maintenance of overnight euglycemia and the calculation of basal insulin requirements in insulin-dependent diabetics. , 1982, Annals of internal medicine.